A detailed history of Parsons Capital Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Parsons Capital Management Inc holds 3,769 shares of EW stock, worth $248,150. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,769
Previous 3,769 -0.0%
Holding current value
$248,150
Previous $348,000 28.74%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$84.3 - $94.31 $5,648 - $6,318
-67 Reduced 1.75%
3,769 $348,000
Q1 2024

Apr 22, 2024

SELL
$72.54 - $95.56 $652 - $860
-9 Reduced 0.23%
3,836 $366,000
Q4 2023

Jan 22, 2024

BUY
$61.71 - $77.76 $740 - $933
12 Added 0.31%
3,845 $293,000
Q3 2023

Nov 06, 2023

BUY
$69.28 - $93.38 $554 - $747
8 Added 0.21%
3,833 $265,000
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $651 - $754
-8 Reduced 0.21%
3,825 $360,000
Q1 2023

Apr 17, 2023

SELL
$74.26 - $84.51 $8,539 - $9,718
-115 Reduced 2.91%
3,833 $317,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $1,092 - $1,399
16 Added 0.41%
3,948 $294,000
Q3 2022

Oct 26, 2022

BUY
$82.37 - $107.29 $1,894 - $2,467
23 Added 0.59%
3,932 $325,000
Q2 2022

Jul 29, 2022

BUY
$86.5 - $128.27 $4,498 - $6,670
52 Added 1.35%
3,909 $372,000
Q1 2022

May 02, 2022

BUY
$101.96 - $128.34 $9,074 - $11,422
89 Added 2.36%
3,857 $454,000
Q4 2021

Feb 07, 2022

SELL
$106.37 - $130.68 $106 - $130
-1 Reduced 0.03%
3,768 $488,000
Q3 2021

Nov 09, 2021

SELL
$102.91 - $122.75 $823 - $982
-8 Reduced 0.21%
3,769 $427,000
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $167 - $209
2 Added 0.05%
3,777 $391,000
Q1 2021

Apr 28, 2021

BUY
$78.68 - $90.67 $236 - $272
3 Added 0.08%
3,775 $316,000
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $71 - $91
1 Added 0.03%
3,772 $344,000
Q3 2020

Oct 29, 2020

BUY
$67.19 - $87.44 $201 - $262
3 Added 0.08%
3,771 $301,000
Q2 2020

Aug 10, 2020

BUY
$57.54 - $76.95 $144,540 - $193,298
2,512 Added 200.0%
3,768 $260,000
Q1 2020

May 05, 2020

SELL
$52.41 - $81.0 $12,840 - $19,845
-245 Reduced 16.32%
1,256 $237,000
Q4 2019

Feb 03, 2020

BUY
$71.7 - $82.09 $14,268 - $16,335
199 Added 15.28%
1,501 $350,000
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $4,800 - $5,883
-78 Reduced 5.65%
1,302 $286,000
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $55 - $64
-1 Reduced 0.07%
1,380 $255,000
Q1 2019

Apr 26, 2019

BUY
$47.89 - $64.05 $66,136 - $88,453
1,381 New
1,381 $264,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.